What does the 2027 ASC final rule pay for cataract surgery?
As of November 2026, the CY 2027 OPPS and ASC final rule is a Medicare payment rule that raises the ASC update 2.3% but still lowers the national ASC facility rate for routine cataract surgery, CPT 66984, from $1,255.73 to $1,220.03 starting January 1, 2027. That is a 2.8% cut on Medicare’s highest-volume ASC procedure.
Most eye codes fall: Of 259 ophthalmic ASC codes with rates in both years, 250 pay less in 2027, by an average of about 3.4%.
Device-intensive codes rise: Cataract surgery combined with a MIGS device, CPT 66991, climbs 8.5% to $4,356.03.
Biggest single drop: Amniotic membrane transplant, CPT 65780, loses device-intensive status and falls 23.4% to $1,685.61.
What CMS Finalized on November 4, 2026
The Centers for Medicare and Medicaid Services released the CY 2027 Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System final rule, CMS-1850-FC, on November 4, 2026. The rates take effect for ASC claims with dates of service on or after January 1, 2027. The rule, its addenda, and the supporting files are posted on the CMS-1850-FC final rule page.
The headline number is a 2.3% payment update for ASCs that meet quality reporting requirements, down from the 2.4% CMS proposed in July. The update reflects a 3.2% hospital market basket reduced by a 0.9% productivity adjustment. CMS also extended its use of the hospital market basket, rather than the consumer price index, to update ASC rates through 2027 only, so the method returns for debate in next year’s rule.
For ophthalmology, the headline update hides the real story. The American Academy of Ophthalmology described the rule on November 5, 2026 as delivering pay raises for device-intensive procedures but cuts to other common ophthalmic surgeries. Our review of the final Addendum AA confirms that pattern code by code: the 2.3% update does not reach most eye procedures, because the relative weights under them fell faster than the conversion factor rose.
Becker’s ASC, reporting CMS’s own impact estimates, notes that cataract removal is the largest Medicare ASC procedure by spending at about $1.38 billion, and that CMS projects aggregate 66984 payments to fall 2% in 2027. That projection includes expected volume changes. On a per-case basis, the final national rate falls 2.8%, which is the figure a surgery center will see on each remittance.
How much will ASCs be paid for eye procedures in 2027?
Under the final rule, national ASC rates fall for most eye procedures in 2027. Cataract surgery, CPT 66984, drops to $1,220.03, YAG capsulotomy, CPT 66821, drops to $290.54, and upper eyelid blepharoplasty, CPT 15823, drops to $1,056.08. Device-intensive glaucoma and combined cataract and MIGS procedures increase.
| CPT code | Procedure | 2026 ASC rate | 2027 ASC rate | Change |
|---|---|---|---|---|
| 66984 | Cataract surgery with IOL, routine | $1,255.73 | $1,220.03 | -2.8% |
| 66982 | Cataract surgery with IOL, complex | $1,255.73 | $1,220.03 | -2.8% |
| 66991 | Cataract surgery with MIGS device | $4,014.69 | $4,356.03 | +8.5% |
| 66989 | Complex cataract with MIGS device | $3,973.89 | $4,271.16 | +7.5% |
| 66183 | Anterior segment drainage device | $3,207.67 | $3,452.52 | +7.6% |
| 66821 | YAG capsulotomy | $301.90 | $290.54 | -3.8% |
| 67108 | Retinal detachment repair | $2,203.87 | $2,160.65 | -2.0% |
| 15823 | Upper eyelid blepharoplasty | $1,128.57 | $1,056.08 | -6.4% |
| 65780 | Amniotic membrane transplant | $2,199.20 | $1,685.61 | -23.4% |
The 2026 figures are CMS’s October 2026 ASC payment rates, and the 2027 figures are the final Addendum AA rates for ASCs meeting quality reporting requirements. Both are national, before the wage index adjustment, which CMS applies to 50% of each ASC rate.
The math behind the cataract cut is worth understanding. The implied ASC conversion factor rises from about $56.32 to about $57.72, but the relative weight for 66984 falls from 22.2955 to 21.1366, roughly a 5.2% drop. Because the weight falls faster than the conversion factor rises, the rate goes down. Device-intensive procedures, flagged with payment indicator J8, are paid differently: the device portion is carried over from the hospital outpatient rate, which is why 66991, 66989, and 66183 move in the opposite direction.
Which ophthalmology ASCs are hit hardest?
Cataract-focused ASCs feel the 2027 rule most, because 66984 dominates their Medicare volume and loses $35.70 per case. Oculoplastic centers lose 6.4% on upper eyelid blepharoplasty, and cornea practices lose the most per case on amniotic membrane transplant. Centers that perform combined cataract and MIGS cases gain on those codes.
Here is what that looks like at a working surgery center. Take an illustrative ASC performing 150 Medicare cataract cases a month, or 1,800 a year. At the 2027 national rate, that ASC collects about $64,260 less in facility payments for the same work, before the wage index adjustment. A center that converts even a modest share of eligible glaucoma patients to combined procedures will see a different 2027, because 66991 rises by $341.34 per case.
The amniotic membrane change is the one most centers will miss. CPT 65780 loses its device-intensive status and moves to payment indicator A2, so the device portion no longer carries forward. If your surgeons use amniotic tissue in pterygium or ocular surface reconstruction, model those cases now, because a $513.59 drop per case can turn a profitable case into a loss once tissue costs are counted. CPT 67550, orbital implant insertion, moves the other way and gains device-intensive status.
The most common issue we see providers run into after an ASC rate change is that the professional and facility sides get analyzed separately. Surgeons budget for their physician fee schedule cut, administrators budget for the facility cut, and nobody adds the two together until the first quarter closes.
What should ophthalmology ASCs do before January 1, 2027?
Ophthalmology ASCs should load the final 2027 Addendum AA rates, apply their wage index, reprice cataract and MIGS case costs, review amniotic membrane and blepharoplasty margins, and confirm that Medicare Advantage contracts tied to Medicare rates will update. Finishing in November and December keeps January claims and estimates accurate.
- Load the final 2027 Addendum AA rates into your ASC billing system before the first January date of service.
- Apply your CBSA wage index to 50% of each rate so budgets reflect local payment rather than the national figure.
- Reprice your top 20 procedures against supply and implant costs, starting with 66984, 66991, and 65780.
- Check Medicare Advantage and commercial contracts that pay a percentage of the Medicare ASC rate, since those rates usually move with it.
- Confirm your ASC met Ambulatory Surgical Center Quality Reporting requirements, because noncompliance reduces the update by 2 percentage points.
- Audit second-eye cataract claims for correct use of modifier 79 so facility and professional claims line up during the global period.
One question we hear constantly from ASC administrators is whether a rate cut means a staffing cut. Usually it does not, but it does mean every denied or underpaid claim matters more. A 2.8% rate drop leaves very little room for claims that go out without the right implant codes, modifiers, or laterality. On a cataract-heavy schedule, a single week of rejected claims can erase a month of the margin the center was counting on, so January is the wrong time to discover a configuration error.
ASC rate cuts make every denied claim more expensive. Compare ophthalmology billing companies in our network that handle ASC and professional claims, with rates starting as low as 2.95%, and hear from a matched partner typically within 2 hours.
Common Misreadings of the ASC Final Rule
The first misreading is that a 2.3% update means ASC rates go up. For ophthalmology, the opposite is true. Of the 259 eye procedure codes with rates in both years, only 9 pay more in 2027, and almost all of those are device-intensive. The update applies to the conversion factor, not to each procedure’s weight.
The second misreading is treating CMS’s 2% cataract projection as the per-case change. That figure estimates aggregate spending, including projected volume. The final national rate for 66984 falls 2.8% per case, and that is the number to use when updating fee schedules and patient estimates.
Third, some centers assume the physician fee schedule cut and the ASC cut are the same event. They are separate rules with separate rates. The professional payment for cataract surgery is set by the CY 2027 Physician Fee Schedule final rule, released the same day, while the facility payment comes from the OPPS and ASC rule. A cataract case is hit twice, once on each side.
Fourth, device-intensive gains are not automatic. The higher rates for 66991, 66989, and 66183 apply only when the device code is billed correctly and the case meets the clinical criteria in your Medicare contractor’s policy. A missing device line or an unsupported glaucoma diagnosis converts a winning code into a denial.
Finally, the rates in the addenda are national and unadjusted. A center in a low wage index area will see a lower dollar figure than the national rate, and a center in a high wage area will see a higher one, even though the percentage change is the same.
In-House Billing vs. an Ophthalmology Billing Partner
An annual ASC rate change tests every part of the revenue cycle at once. Someone has to load new rates, reprice cases, update patient estimates, reconcile January remittances, and catch Medicare Advantage plans that update late or not at all. In a surgery center that also runs physician billing, the same small team often handles both sides of every case. That is when implant codes get dropped, second-eye modifiers get mismatched, and late Medicare Advantage updates go unnoticed for months.
In our experience matching providers with billing partners, ophthalmology groups that own or co-own an ASC benefit most from a partner that handles facility and professional claims together, because the two claims for one cataract case must agree on dates, laterality, modifiers, and implant codes. Ophthalmology Bill Co has connected more than 200 ophthalmology providers with a network of more than 30 ophthalmology-certified billing companies, and a matched partner typically contacts the practice within 2 hours.
The company reports that practices matched through its network see average claim denial reductions of 5% to 7% within the first 90 days, and many see reimbursement rates rise when contracts come up for renegotiation. Tim Daniels, Director of Strategic Accounts at Billing Service Quotes, oversees the matching process, and you can learn more about Ophthalmology Bill Co and how the referral model works. The match is free, and you are never obligated to hire the company you are introduced to. Partners in the network cover all ophthalmology subspecialties, including cataract and retina, in all 50 states.
Frequently Asked Questions
The CY 2027 ASC payment rates take effect for dates of service on or after January 1, 2027. Cataract cases performed on December 31, 2026 are paid at 2026 rates even when the claim is submitted in January. CMS released the final rule, CMS-1850-FC, on November 4, 2026.
The 2027 national ASC payment rate for CPT 66984, routine cataract surgery with intraocular lens, is $1,220.03 for centers meeting quality reporting requirements. That is down from $1,255.73 in 2026. Your actual payment is adjusted by your area’s wage index, which applies to half of the rate.
Codes 66989 and 66991 are device-intensive procedures. Medicare pays their device portion based on the hospital outpatient rate rather than the ASC weight, so they are not pulled down by the ASC weight scalar. In 2027, 66991 rises 8.5% to $4,356.03 and 66989 rises 7.5% to $4,271.16.
No new ophthalmic codes appear on the final 2027 ASC covered procedures list, based on a comparison of the October 2026 and final 2027 Addendum AA files. CMS added hundreds of codes overall, mostly outside ophthalmology. Two eye codes changed payment status: 65780 and 67550.
No. The ASC rule sets only the facility payment. The surgeon’s professional payment for 66984 comes from the CY 2027 Physician Fee Schedule final rule, released the same day, which lowered the nonqualifying APM conversion factor 2.31%. A cataract case is affected by both rules.
ASCs that fail Ambulatory Surgical Center Quality Reporting requirements receive a 2 percentage point reduction to the annual update, so their 2027 rates are lower than the national figures published for compliant centers. The reduction applies to every procedure the center bills to Medicare that year.
Next Steps
Load the final 2027 Addendum AA rates, apply your wage index, and reprice 66984, 66991, and 65780 against current supply and implant costs before January. Share the new numbers with your surgeons so case scheduling and device decisions reflect what the center will actually be paid.
Review modifier 79 billing for second-eye cataract surgery and your pre-operative CPT 92134 retinal OCT claims so both sides of each case go out clean and match on dates, laterality, and modifiers.
If your team is stretched across facility and professional billing, compare ophthalmology billing companies matched to your ASC and practice at no cost. A matched partner typically reaches out within 2 hours, and the introduction costs nothing.
Get matched with an ophthalmology billing company that handles ASC rate changes every year. Rates start as low as 2.95%, and the match is free.
